4 months progress. Hims spray. 6% min, 0.3% fin. Also .25mm dermaroller 2x a week. Progress Pictures 6/21/2023
A user's successful 4-month hair growth progress using Hims spray with 6% Minoxidil, 0.3% Finasteride, and a .25mm dermaroller twice a week. The user applies the spray once a day and has not experienced any side effects.
View this post in the Community →
Similar Community Posts Join
5 / 1000+ resultscommunity Update: 16 months deep - big 3
The user has seen positive results after 16 months of using topical Finasteride/Minoxidil, microneedling weekly, and Tretinoin for hair loss. There are no reported side effects, and the user advises that the effectiveness of microneedling depends on the pressure applied.
community 5 month progress on topical min + fin!
A user shared their 5-month progress using topical minoxidil and finasteride for hair loss. Others congratulated and suggested a haircut style.
community Fin min micro 2 years. Last pic is for proof fin doesn’t ruin your muscle gains
The conclusion of the conversation is that the user, ZadarskiDrake, has been using minoxidil and finasteride for two years to treat hair loss. They apply minoxidil at night and have not experienced negative effects on muscle gains. They also mention using a needle pin for hair treatment.
community Two month progress on minoxidil and finasteride.
A 34-year-old man successfully regrew hair using a routine of Hims finasteride/minoxidil spray, biotin, multivitamins, Nizoral 1% keto shampoo, and derma rolling. He also mentioned lifestyle changes like quitting alcohol, stopping creatine, and regular exercise.
community Results after more than 1.5 years on Finasteride
A user shared their experience with finasteride for hair loss, noting it slowed but didn't stop their hair loss, and they quit after 1.5 years. Suggestions included trying dutasteride, adding minoxidil, and maintaining a healthy lifestyle.
Related Research
6 / 31 results
research Index
The document is a detailed medical reference on skin and genetic disorders.
research Response to Ranpariya et al.'s 'Direct-to-Consumer Teledermatology Platforms May Have Inherent Conflicts of Interest'
Direct-to-consumer teledermatology platforms have financial conflicts of interest and lack proper patient care and follow-up.
research Long-Term Efficacy of Baricitinib in the Treatment of Alopecia Areata: Results at Week 104 from the BRAVE-AA1 and BRAVE-AA2 Studies
Baricitinib effectively treats severe alopecia for up to 104 weeks.
research Shock Wave Therapy for Erectile Dysfunction: Marketing and Practice Trends in Major Metropolitan Areas in the United States
Patients should consult urologists for evidence-based erectile dysfunction treatments.
research Direct-To-Consumer Teledermatology’s Limitations May Be Addressed With Greater In-Person Care Synergy
Combining online and in-person dermatology care can improve quality and access.
research Digital Health Platforms Expand Access and Improve Care for Male Androgenetic Alopecia
Digital health platforms improve treatment for male pattern hair loss.